PHOREMOST
PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.
PHOREMOST
Industry:
Biopharma Biotechnology Health Care
Founded:
2014-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.phoremost.com
Total Employee:
1+
Status:
Active
Contact:
+4401223437110
Email Addresses:
[email protected]
Total Funding:
64.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Euro Microsoft Exchange Online
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
O2h Ventures
O2h Ventures investment in Series B - PhoreMost
Trend Investment Group
Trend Investment Group investment in Series B - PhoreMost
Parkwalk Advisors
Parkwalk Advisors investment in Series B - PhoreMost
Jonathan Milner
Jonathan Milner investment in Series B - PhoreMost
Morningside Venture Investments
Morningside Venture Investments investment in Series B - PhoreMost
Business Growth Fund
Business Growth Fund investment in Series B - PhoreMost
Astellas Venture Management
Astellas Venture Management investment in Series B - PhoreMost
XtalPi
XtalPi investment in Series B - PhoreMost
Amadeus Capital Partners
Amadeus Capital Partners investment in Series A - PhoreMost
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series A - PhoreMost
Official Site Inspections
http://www.phoremost.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.28 K
- Host name: kisscab2.miniserver.com
- IP address: 89.200.137.201
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "PhoreMost"
PhoreMost - Crunchbase Company Profile & Funding
PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working …See details»
PhoreMost Ltd - LinkedIn
PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®â€™ disease targets using our next-generation technology, SITESEEKER®.See details»
PhoreMost - Lab Manager
Jun 24, 2018 Organization profile for PhoreMost on Lab Manager. PhoreMost has built a …See details»
PhoreMost Company Profile - Office Locations, Competitors ... - Craft
PhoreMost is a company specializing in drug discovery. It develops the SiteSeeker technology, …See details»
PhoreMost Ltd - Cambridge, United Kingdom - bionity.com
PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core …See details»
About - PhoreMost
PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® which can discern the best new targets for future therapies and, crucially, how to drug them. This has the potential to significantly increase the …See details»
PhoreMost Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Press release: PhoreMost and Boehringer Ingelheim enter multi-project drug discovery …See details»
PhoreMost - VentureRadar
PhoreMost is a new-model drug discovery company based in Cambridge, UK.PhoreMost is …See details»
PhoreMost Ltd Management Team | Org Chart - RocketReach
Top PhoreMost Ltd Management Employees Neil Torbett Chief Executive Officer at PhoreMost …See details»
PhoreMost - Contacts, Employees, Board Members, Advisors
Organization. PhoreMost . Connect to CRM . Save . Summary. Financials. People. …See details»
Careers - PhoreMost
PhoreMost’s internal Talent Acquisition team members are the only PhoreMost personnel …See details»
PhoreMost enters multi-project drug target discovery …
Cambridge, UK, 06 September 2022: PhoreMost Ltd., the UK-based biopharmaceutical …See details»
Contact - PhoreMost
Through its SITESEEKER® drug target identification platform, PhoreMost is expanding …See details»
PhoreMost closes £33M ($46M) Series B financing - PhoreMost
Cambridge, UK, 23 March 2021: PhoreMost Ltd., the UK-based biopharmaceutical company …See details»
Science - PhoreMost
PhoreMost’s platform has the ability to unlock its full potential and capitalise on this crucial new …See details»
PhoreMost makes key appointments to Board to advance …
May 12, 2025 PhoreMost Ltd., a next-generation targeted protein degradation (TPD) …See details»
PhoreMost LTD Profile | The Scientist
Oct 17, 2016 This organization does not yet have a description. Login. Subscribe. News; …See details»
Neil Torbett - CEO & Director at PhoreMost - The Org
He joined PhoreMost in January 2017, serving as Chief Business Officer before being …See details»
PhoreMost received $12,000,000 in an epic growth funding round.
Sep 11, 2024 PhoreMost Ltd., a prominent biopharmaceutical company headquartered in …See details»